MedTrace Logo

Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery

NCT03512223 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-11-01

No results posted yet for this study

Summary

This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery.

Conditions

  • Hand Surgery

Interventions

DRUG

Dexamethasone

Intravenous and Perineural Dexamethasone for Brachial Plexus Block

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Michael Kushelev, MD · Assistant Professor-Clinical

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-23
Primary Completion
2024-10-20
Completion
2024-10-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512223 on ClinicalTrials.gov